HEADER HYDROLASE/HYDROLASE INHIBITOR 05-JAN-16 5HDZ TITLE BACE-1 IN COMPLEX WITH (7AR)-7A-(5-CYANOTHIOPHEN-2-YL)-6-(5-FLUORO-4- TITLE 2 METHYL-6-(METHYLTHIO)PYRIMIDIN-2-YL)-3-METHYL-4-OXOOCTAHYDRO-2H- TITLE 3 PYRROLO[3,4-D]PYRIMIDIN-2-IMINIUM COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SECRETASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 41-454; COMPND 5 SYNONYM: ASPARTYL PROTEASE 2,ASP 2,BETA-SITE AMYLOID PRECURSOR COMPND 6 PROTEIN CLEAVING ENZYME 1,BETA-SITE APP CLEAVING ENZYME 1,MEMAPSIN-2, COMPND 7 MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2; COMPND 8 EC: 3.4.23.46; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BACE1, BACE, KIAA1149; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALZHEIMER'S, ASPARTYL PROTEASE, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.ORTH REVDAT 3 06-NOV-24 5HDZ 1 JRNL REMARK REVDAT 2 27-APR-16 5HDZ 1 JRNL REVDAT 1 16-MAR-16 5HDZ 0 JRNL AUTH M.MANDAL,Y.WU,J.MISIASZEK,G.LI,A.BUEVICH,J.P.CALDWELL,X.LIU, JRNL AUTH 2 R.D.MAZZOLA,P.ORTH,C.STRICKLAND,J.VOIGT,H.WANG,Z.ZHU,X.CHEN, JRNL AUTH 3 M.GRZELAK,L.A.HYDE,R.KUVELKAR,P.T.LEACH,G.TERRACINA,L.ZHANG, JRNL AUTH 4 Q.ZHANG,M.S.MICHENER,B.SMITH,K.COX,D.GROTZ,L.FAVREAU, JRNL AUTH 5 K.MITRA,I.KAZAKEVICH,B.A.MCKITTRICK,W.GREENLEE,M.E.KENNEDY, JRNL AUTH 6 E.M.PARKER,J.N.CUMMING,A.W.STAMFORD JRNL TITL STRUCTURE-BASED DESIGN OF AN IMINOHETEROCYCLIC BETA-SITE JRNL TITL 2 AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME (BACE) INHIBITOR JRNL TITL 3 THAT LOWERS CENTRAL A BETA IN NONHUMAN PRIMATES. JRNL REF J.MED.CHEM. V. 59 3231 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26937601 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01995 REMARK 2 REMARK 2 RESOLUTION. 1.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 161753 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.010 REMARK 3 FREE R VALUE TEST SET COUNT : 6485 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.49 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.53 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.37 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 11652 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1983 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 11186 REMARK 3 BIN R VALUE (WORKING SET) : 0.1978 REMARK 3 BIN FREE R VALUE : 0.2095 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 466 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6023 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 896 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.06990 REMARK 3 B22 (A**2) : -4.95690 REMARK 3 B33 (A**2) : 0.88710 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.198 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6242 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8503 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2071 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 141 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 952 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6242 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 795 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 8005 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.62 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 13.88 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HDZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000216887. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 164629 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.490 REMARK 200 RESOLUTION RANGE LOW (A) : 131.554 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 3350, 200MM NA/K TARTRATE, REMARK 280 100MM HEPES, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.15150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.77700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.95700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.77700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.15150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.95700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 41 REMARK 465 ARG A 42 REMARK 465 LEU A 43 REMARK 465 PRO A 44 REMARK 465 ARG A 45 REMARK 465 GLU A 46 REMARK 465 THR A 47 REMARK 465 ASP A 48 REMARK 465 GLU A 49 REMARK 465 GLU A 50 REMARK 465 PRO A 51 REMARK 465 GLU A 52 REMARK 465 GLU A 53 REMARK 465 PRO A 54 REMARK 465 GLY A 55 REMARK 465 ARG A 56 REMARK 465 ARG A 57 REMARK 465 VAL A 373 REMARK 465 ALA A 374 REMARK 465 THR A 375 REMARK 465 PRO A 448 REMARK 465 GLN A 449 REMARK 465 THR A 450 REMARK 465 ASP A 451 REMARK 465 GLU A 452 REMARK 465 SER A 453 REMARK 465 THR A 454 REMARK 465 LEU B 41 REMARK 465 ARG B 42 REMARK 465 LEU B 43 REMARK 465 PRO B 44 REMARK 465 ARG B 45 REMARK 465 GLU B 46 REMARK 465 THR B 47 REMARK 465 ASP B 48 REMARK 465 GLU B 49 REMARK 465 GLU B 50 REMARK 465 PRO B 51 REMARK 465 GLU B 52 REMARK 465 GLU B 53 REMARK 465 PRO B 54 REMARK 465 GLY B 55 REMARK 465 ARG B 56 REMARK 465 ARG B 57 REMARK 465 VAL B 373 REMARK 465 ALA B 374 REMARK 465 THR B 375 REMARK 465 ILE B 447 REMARK 465 PRO B 448 REMARK 465 GLN B 449 REMARK 465 THR B 450 REMARK 465 ASP B 451 REMARK 465 GLU B 452 REMARK 465 SER B 453 REMARK 465 THR B 454 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 96 C REMARK 470 HIS A 110 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 134 CG CD OE1 NE2 REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 ASP A 167 CG OD1 OD2 REMARK 470 LYS A 168 CG CD CE NZ REMARK 470 LYS A 203 CE NZ REMARK 470 GLN A 224 CG CD OE1 NE2 REMARK 470 TYR A 259 CZ REMARK 470 LYS A 275 CD CE NZ REMARK 470 GLU A 441 CG CD OE1 OE2 REMARK 470 GLN B 134 CG CD OE1 NE2 REMARK 470 LYS B 203 CE NZ REMARK 470 GLN B 224 CG CD OE1 NE2 REMARK 470 LYS B 300 CE NZ REMARK 470 GLU B 441 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 150 57.98 -105.30 REMARK 500 PHE A 169 -60.23 -98.52 REMARK 500 ASP A 192 0.08 -68.93 REMARK 500 TRP A 258 -84.19 -144.43 REMARK 500 HIS B 150 49.71 -105.42 REMARK 500 ASP B 192 0.37 -68.58 REMARK 500 TRP B 258 -83.75 -144.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 954 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 954 B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5HE5 RELATED DB: PDB REMARK 900 RELATED ID: 5HE4 RELATED DB: PDB REMARK 900 RELATED ID: 5HDX RELATED DB: PDB REMARK 900 RELATED ID: 5HDV RELATED DB: PDB REMARK 900 RELATED ID: 5HDU RELATED DB: PDB REMARK 900 RELATED ID: 5HE7 RELATED DB: PDB REMARK 900 RELATED ID: 5HD0 RELATED DB: PDB DBREF 5HDZ A 41 454 UNP P56817 BACE1_HUMAN 41 454 DBREF 5HDZ B 41 454 UNP P56817 BACE1_HUMAN 41 454 SEQRES 1 A 414 LEU ARG LEU PRO ARG GLU THR ASP GLU GLU PRO GLU GLU SEQRES 2 A 414 PRO GLY ARG ARG GLY SER PHE VAL GLU MET VAL ASP ASN SEQRES 3 A 414 LEU ARG GLY LYS SER GLY GLN GLY TYR TYR VAL GLU MET SEQRES 4 A 414 THR VAL GLY SER PRO PRO GLN THR LEU ASN ILE LEU VAL SEQRES 5 A 414 ASP THR GLY SER SER ASN PHE ALA VAL GLY ALA ALA PRO SEQRES 6 A 414 HIS PRO PHE LEU HIS ARG TYR TYR GLN ARG GLN LEU SER SEQRES 7 A 414 SER THR TYR ARG ASP LEU ARG LYS GLY VAL TYR VAL PRO SEQRES 8 A 414 TYR THR GLN GLY LYS TRP GLU GLY GLU LEU GLY THR ASP SEQRES 9 A 414 LEU VAL SER ILE PRO HIS GLY PRO ASN VAL THR VAL ARG SEQRES 10 A 414 ALA ASN ILE ALA ALA ILE THR GLU SER ASP LYS PHE PHE SEQRES 11 A 414 ILE ASN GLY SER ASN TRP GLU GLY ILE LEU GLY LEU ALA SEQRES 12 A 414 TYR ALA GLU ILE ALA ARG PRO ASP ASP SER LEU GLU PRO SEQRES 13 A 414 PHE PHE ASP SER LEU VAL LYS GLN THR HIS VAL PRO ASN SEQRES 14 A 414 LEU PHE SER LEU GLN LEU CYS GLY ALA GLY PHE PRO LEU SEQRES 15 A 414 ASN GLN SER GLU VAL LEU ALA SER VAL GLY GLY SER MET SEQRES 16 A 414 ILE ILE GLY GLY ILE ASP HIS SER LEU TYR THR GLY SER SEQRES 17 A 414 LEU TRP TYR THR PRO ILE ARG ARG GLU TRP TYR TYR GLU SEQRES 18 A 414 VAL ILE ILE VAL ARG VAL GLU ILE ASN GLY GLN ASP LEU SEQRES 19 A 414 LYS MET ASP CYS LYS GLU TYR ASN TYR ASP LYS SER ILE SEQRES 20 A 414 VAL ASP SER GLY THR THR ASN LEU ARG LEU PRO LYS LYS SEQRES 21 A 414 VAL PHE GLU ALA ALA VAL LYS SER ILE LYS ALA ALA SER SEQRES 22 A 414 SER THR GLU LYS PHE PRO ASP GLY PHE TRP LEU GLY GLU SEQRES 23 A 414 GLN LEU VAL CYS TRP GLN ALA GLY THR THR PRO TRP ASN SEQRES 24 A 414 ILE PHE PRO VAL ILE SER LEU TYR LEU MET GLY GLU VAL SEQRES 25 A 414 THR ASN GLN SER PHE ARG ILE THR ILE LEU PRO GLN GLN SEQRES 26 A 414 TYR LEU ARG PRO VAL GLU ASP VAL ALA THR SER GLN ASP SEQRES 27 A 414 ASP CYS TYR LYS PHE ALA ILE SER GLN SER SER THR GLY SEQRES 28 A 414 THR VAL MET GLY ALA VAL ILE MET GLU GLY PHE TYR VAL SEQRES 29 A 414 VAL PHE ASP ARG ALA ARG LYS ARG ILE GLY PHE ALA VAL SEQRES 30 A 414 SER ALA CYS HIS VAL HIS ASP GLU PHE ARG THR ALA ALA SEQRES 31 A 414 VAL GLU GLY PRO PHE VAL THR LEU ASP MET GLU ASP CYS SEQRES 32 A 414 GLY TYR ASN ILE PRO GLN THR ASP GLU SER THR SEQRES 1 B 414 LEU ARG LEU PRO ARG GLU THR ASP GLU GLU PRO GLU GLU SEQRES 2 B 414 PRO GLY ARG ARG GLY SER PHE VAL GLU MET VAL ASP ASN SEQRES 3 B 414 LEU ARG GLY LYS SER GLY GLN GLY TYR TYR VAL GLU MET SEQRES 4 B 414 THR VAL GLY SER PRO PRO GLN THR LEU ASN ILE LEU VAL SEQRES 5 B 414 ASP THR GLY SER SER ASN PHE ALA VAL GLY ALA ALA PRO SEQRES 6 B 414 HIS PRO PHE LEU HIS ARG TYR TYR GLN ARG GLN LEU SER SEQRES 7 B 414 SER THR TYR ARG ASP LEU ARG LYS GLY VAL TYR VAL PRO SEQRES 8 B 414 TYR THR GLN GLY LYS TRP GLU GLY GLU LEU GLY THR ASP SEQRES 9 B 414 LEU VAL SER ILE PRO HIS GLY PRO ASN VAL THR VAL ARG SEQRES 10 B 414 ALA ASN ILE ALA ALA ILE THR GLU SER ASP LYS PHE PHE SEQRES 11 B 414 ILE ASN GLY SER ASN TRP GLU GLY ILE LEU GLY LEU ALA SEQRES 12 B 414 TYR ALA GLU ILE ALA ARG PRO ASP ASP SER LEU GLU PRO SEQRES 13 B 414 PHE PHE ASP SER LEU VAL LYS GLN THR HIS VAL PRO ASN SEQRES 14 B 414 LEU PHE SER LEU GLN LEU CYS GLY ALA GLY PHE PRO LEU SEQRES 15 B 414 ASN GLN SER GLU VAL LEU ALA SER VAL GLY GLY SER MET SEQRES 16 B 414 ILE ILE GLY GLY ILE ASP HIS SER LEU TYR THR GLY SER SEQRES 17 B 414 LEU TRP TYR THR PRO ILE ARG ARG GLU TRP TYR TYR GLU SEQRES 18 B 414 VAL ILE ILE VAL ARG VAL GLU ILE ASN GLY GLN ASP LEU SEQRES 19 B 414 LYS MET ASP CYS LYS GLU TYR ASN TYR ASP LYS SER ILE SEQRES 20 B 414 VAL ASP SER GLY THR THR ASN LEU ARG LEU PRO LYS LYS SEQRES 21 B 414 VAL PHE GLU ALA ALA VAL LYS SER ILE LYS ALA ALA SER SEQRES 22 B 414 SER THR GLU LYS PHE PRO ASP GLY PHE TRP LEU GLY GLU SEQRES 23 B 414 GLN LEU VAL CYS TRP GLN ALA GLY THR THR PRO TRP ASN SEQRES 24 B 414 ILE PHE PRO VAL ILE SER LEU TYR LEU MET GLY GLU VAL SEQRES 25 B 414 THR ASN GLN SER PHE ARG ILE THR ILE LEU PRO GLN GLN SEQRES 26 B 414 TYR LEU ARG PRO VAL GLU ASP VAL ALA THR SER GLN ASP SEQRES 27 B 414 ASP CYS TYR LYS PHE ALA ILE SER GLN SER SER THR GLY SEQRES 28 B 414 THR VAL MET GLY ALA VAL ILE MET GLU GLY PHE TYR VAL SEQRES 29 B 414 VAL PHE ASP ARG ALA ARG LYS ARG ILE GLY PHE ALA VAL SEQRES 30 B 414 SER ALA CYS HIS VAL HIS ASP GLU PHE ARG THR ALA ALA SEQRES 31 B 414 VAL GLU GLY PRO PHE VAL THR LEU ASP MET GLU ASP CYS SEQRES 32 B 414 GLY TYR ASN ILE PRO GLN THR ASP GLU SER THR HET 954 A 501 29 HET 954 B 501 29 HETNAM 954 5-{(2E,4AR,7AR)-6-[5-FLUORO-4-METHYL-6- HETNAM 2 954 (METHYLSULFANYL)PYRIMIDIN-2-YL]-2-IMINO-3-METHYL-4- HETNAM 3 954 OXOOCTAHYDRO-7AH-PYRROLO[3,4-D]PYRIMIDIN-7A- HETNAM 4 954 YL}THIOPHENE-2-CARBONITRILE FORMUL 3 954 2(C18 H18 F N7 O S2) FORMUL 5 HOH *896(H2 O) HELIX 1 AA1 GLN A 114 SER A 118 5 5 HELIX 2 AA2 TYR A 184 ALA A 188 5 5 HELIX 3 AA3 PRO A 196 THR A 205 1 10 HELIX 4 AA4 ASN A 223 SER A 230 1 8 HELIX 5 AA5 ASP A 241 SER A 243 5 3 HELIX 6 AA6 ASP A 277 TYR A 283 5 7 HELIX 7 AA7 LYS A 299 SER A 313 1 15 HELIX 8 AA8 PRO A 319 LEU A 324 1 6 HELIX 9 AA9 PRO A 337 PHE A 341 5 5 HELIX 10 AB1 LEU A 362 TYR A 366 1 5 HELIX 11 AB2 GLY A 395 GLU A 400 1 6 HELIX 12 AB3 ASP A 439 GLY A 444 5 6 HELIX 13 AB4 GLN B 114 SER B 118 5 5 HELIX 14 AB5 TYR B 184 ALA B 188 5 5 HELIX 15 AB6 PRO B 196 THR B 205 1 10 HELIX 16 AB7 ASN B 223 SER B 230 1 8 HELIX 17 AB8 ASP B 241 SER B 243 5 3 HELIX 18 AB9 ASP B 277 TYR B 283 5 7 HELIX 19 AC1 LYS B 299 SER B 313 1 15 HELIX 20 AC2 PRO B 319 LEU B 324 1 6 HELIX 21 AC3 PRO B 337 PHE B 341 5 5 HELIX 22 AC4 LEU B 362 TYR B 366 1 5 HELIX 23 AC5 GLY B 395 GLU B 400 1 6 HELIX 24 AC6 ASP B 439 GLY B 444 5 6 SHEET 1 AA1 8 LEU A 67 LYS A 70 0 SHEET 2 AA1 8 GLY A 74 VAL A 81 -1 O TYR A 76 N ARG A 68 SHEET 3 AA1 8 GLN A 86 ASP A 93 -1 O LEU A 88 N MET A 79 SHEET 4 AA1 8 GLY A 178 GLY A 181 1 O LEU A 180 N LEU A 91 SHEET 5 AA1 8 PHE A 99 GLY A 102 -1 N ALA A 100 O ILE A 179 SHEET 6 AA1 8 THR A 155 ASP A 167 1 O ILE A 163 N VAL A 101 SHEET 7 AA1 8 LYS A 136 SER A 147 -1 N GLU A 140 O ALA A 162 SHEET 8 AA1 8 ARG A 122 PRO A 131 -1 N LYS A 126 O LEU A 141 SHEET 1 AA2 4 LEU A 67 LYS A 70 0 SHEET 2 AA2 4 GLY A 74 VAL A 81 -1 O TYR A 76 N ARG A 68 SHEET 3 AA2 4 LYS A 136 SER A 147 -1 O SER A 147 N THR A 80 SHEET 4 AA2 4 ARG A 122 PRO A 131 -1 N LYS A 126 O LEU A 141 SHEET 1 AA3 5 GLY A 233 ILE A 237 0 SHEET 2 AA3 5 PHE A 211 LEU A 215 -1 N GLN A 214 O SER A 234 SHEET 3 AA3 5 PHE A 402 ASP A 407 -1 O PHE A 406 N PHE A 211 SHEET 4 AA3 5 ARG A 412 SER A 418 -1 O ALA A 416 N TYR A 403 SHEET 5 AA3 5 TYR A 245 PRO A 253 -1 N THR A 252 O ILE A 413 SHEET 1 AA4 5 GLN A 272 ASP A 273 0 SHEET 2 AA4 5 ILE A 264 ILE A 269 -1 N ILE A 269 O GLN A 272 SHEET 3 AA4 5 ILE A 344 MET A 349 -1 O TYR A 347 N ARG A 266 SHEET 4 AA4 5 GLN A 355 ILE A 361 -1 O ILE A 361 N ILE A 344 SHEET 5 AA4 5 ALA A 430 VAL A 436 -1 O GLU A 432 N ARG A 358 SHEET 1 AA5 4 SER A 286 VAL A 288 0 SHEET 2 AA5 4 THR A 392 MET A 394 1 O MET A 394 N ILE A 287 SHEET 3 AA5 4 LEU A 295 PRO A 298 -1 N ARG A 296 O VAL A 393 SHEET 4 AA5 4 ILE A 385 SER A 388 1 O SER A 386 N LEU A 297 SHEET 1 AA6 3 VAL A 329 TRP A 331 0 SHEET 2 AA6 3 ASP A 379 PHE A 383 -1 O ASP A 379 N TRP A 331 SHEET 3 AA6 3 LEU A 367 VAL A 370 -1 N ARG A 368 O LYS A 382 SHEET 1 AA7 8 LEU B 67 LYS B 70 0 SHEET 2 AA7 8 GLY B 74 VAL B 81 -1 O TYR B 76 N ARG B 68 SHEET 3 AA7 8 GLN B 86 ASP B 93 -1 O LEU B 88 N MET B 79 SHEET 4 AA7 8 GLY B 178 GLY B 181 1 O LEU B 180 N LEU B 91 SHEET 5 AA7 8 PHE B 99 GLY B 102 -1 N ALA B 100 O ILE B 179 SHEET 6 AA7 8 THR B 155 ASP B 167 1 O ILE B 163 N VAL B 101 SHEET 7 AA7 8 GLY B 135 SER B 147 -1 N GLU B 140 O ALA B 162 SHEET 8 AA7 8 ARG B 122 TYR B 132 -1 N LYS B 126 O LEU B 141 SHEET 1 AA8 4 LEU B 67 LYS B 70 0 SHEET 2 AA8 4 GLY B 74 VAL B 81 -1 O TYR B 76 N ARG B 68 SHEET 3 AA8 4 GLY B 135 SER B 147 -1 O SER B 147 N THR B 80 SHEET 4 AA8 4 ARG B 122 TYR B 132 -1 N LYS B 126 O LEU B 141 SHEET 1 AA9 5 GLY B 233 ILE B 237 0 SHEET 2 AA9 5 PHE B 211 LEU B 215 -1 N GLN B 214 O SER B 234 SHEET 3 AA9 5 PHE B 402 ASP B 407 -1 O PHE B 406 N PHE B 211 SHEET 4 AA9 5 ARG B 412 SER B 418 -1 O ALA B 416 N TYR B 403 SHEET 5 AA9 5 TYR B 245 PRO B 253 -1 N THR B 252 O ILE B 413 SHEET 1 AB1 5 GLN B 272 ASP B 273 0 SHEET 2 AB1 5 ILE B 264 ILE B 269 -1 N ILE B 269 O GLN B 272 SHEET 3 AB1 5 ILE B 344 MET B 349 -1 O TYR B 347 N ARG B 266 SHEET 4 AB1 5 GLN B 355 ILE B 361 -1 O ILE B 361 N ILE B 344 SHEET 5 AB1 5 ALA B 430 VAL B 436 -1 O GLU B 432 N ARG B 358 SHEET 1 AB2 4 SER B 286 VAL B 288 0 SHEET 2 AB2 4 THR B 392 MET B 394 1 O MET B 394 N ILE B 287 SHEET 3 AB2 4 LEU B 295 PRO B 298 -1 N ARG B 296 O VAL B 393 SHEET 4 AB2 4 ILE B 385 SER B 388 1 O SER B 386 N LEU B 297 SHEET 1 AB3 3 VAL B 329 TRP B 331 0 SHEET 2 AB3 3 ASP B 379 PHE B 383 -1 O ASP B 379 N TRP B 331 SHEET 3 AB3 3 LEU B 367 VAL B 370 -1 N ARG B 368 O LYS B 382 SSBOND 1 CYS A 216 CYS A 420 1555 1555 2.09 SSBOND 2 CYS A 278 CYS A 443 1555 1555 2.04 SSBOND 3 CYS A 330 CYS A 380 1555 1555 2.06 SSBOND 4 CYS B 216 CYS B 420 1555 1555 2.09 SSBOND 5 CYS B 278 CYS B 443 1555 1555 2.03 SSBOND 6 CYS B 330 CYS B 380 1555 1555 2.06 CISPEP 1 SER A 83 PRO A 84 0 -1.73 CISPEP 2 ARG A 189 PRO A 190 0 0.87 CISPEP 3 TYR A 283 ASP A 284 0 2.14 CISPEP 4 GLY A 433 PRO A 434 0 -5.31 CISPEP 5 SER B 83 PRO B 84 0 -1.75 CISPEP 6 ARG B 189 PRO B 190 0 4.32 CISPEP 7 TYR B 283 ASP B 284 0 1.61 CISPEP 8 GLY B 433 PRO B 434 0 -5.74 SITE 1 AC1 16 LEU A 91 ASP A 93 SER A 96 ASN A 98 SITE 2 AC1 16 VAL A 130 TYR A 132 ILE A 171 TRP A 176 SITE 3 AC1 16 ILE A 179 ILE A 187 ARG A 189 ASP A 289 SITE 4 AC1 16 GLY A 291 THR A 292 HOH A 671 HOH A 851 SITE 1 AC2 16 LEU B 91 ASP B 93 SER B 96 ASN B 98 SITE 2 AC2 16 VAL B 130 TYR B 132 ILE B 171 TRP B 176 SITE 3 AC2 16 ILE B 187 ARG B 189 ASP B 289 GLY B 291 SITE 4 AC2 16 THR B 292 HOH B 689 HOH B 719 HOH B 813 CRYST1 86.303 89.914 131.554 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011587 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011122 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007601 0.00000